Replies to post #35771 on Biotech Values

[randychub]

lumpy - You could try the imcl ihub board and ask pharma or walk any question you have on amln. Both good sources of information and both I know owned amln. I am not sure if they still own amln.

R

[north40000]

AMLN

The conveniently-timed Boston Globe scurrilous attack on Byetta was picked up by Reuters. This is LLY's reply:

http://www1.investorvillage.com/smbd.asp?mb=2885&pt=msg&mid=637824

Lumpy, I see no reason to sell AMLN now. Its pipeline in metabolism drugs looks too good, and there is plenty of space
in the diabetes tratment/weight loss arena in U.S., Europe, Asia and Latin America.